BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/28/2020 10:56:28 AM | Browse: 393 | Download: 431
Publication Name World Journal of Meta-Analysis
Manuscript ID 57210
Country/Territory United States
Received
2020-06-01 14:37
Peer-Review Started
2020-05-31 21:58
To Make the First Decision
Return for Revision
2020-10-04 03:23
Revised
2020-10-14 02:51
Second Decision
2020-10-26 00:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2020-10-26 04:01
Articles in Press
2020-10-26 04:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2020-10-28 00:34
Publish the Manuscript Online
2020-10-28 10:48
ISSN 2308-3840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic
Manuscript Source Invited Manuscript
All Author List Maliha Naseer, Shiva Poola, Francis E Dailey, Hakan Akin and Veysel Tahan
Funding Agency and Grant Number
Corresponding Author Veysel Tahan, FACG, FACP, FEBG, MD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri, 1 Hospital Drive, Columbia, MO 65212, United States. tahanv@health.missouri.edu
Key Words SARS-CoV-2; COVID-19; Inflammatory bowel disease; Crohn’s disease; Ulcerative colitis; Pandemic
Core Tip The current pandemic caused by coronavirus disease 2019 (COVID-19) has resulted in devastating consequences worldwide. This viral infection affecting the respiratory and gastrointestinal systems is most severe in patients with co-morbid conditions, including the immunocompromised. Patients with inflammatory bowel disease are often malnourished and on immunosuppressive medications; management of this population poses unique challenges during this time. In this review, we summarize the current evidence and understanding of the management of inflammatory bowel disease during the COVID-19 pandemic. We further outline the current guidelines for treatment of those with inflammatory bowel disease and offer education for measures to prevent infections, including COVID-19.
Publish Date 2020-10-28 10:48
Citation Naseer M, Poola S, Dailey FE, Akin H, Tahan V. Implications of COVID-19 for inflammatory bowel disease: Opportunities and challenges amidst the pandemic. World J Meta-Anal 2020; 8(5): 383-399
URL https://www.wjgnet.com/2308-3840/full/v8/i5/383.htm
DOI https://dx.doi.org/10.13105/wjma.v8.i5.383
Full Article (PDF) WJMA-8-383.pdf
Full Article (Word) WJMA-8-383.docx
Manuscript File 57210_Auto_Edited.docx
Answering Reviewers 57210-Answering reviewers.pdf
Audio Core Tip 57210-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 57210-Conflict-of-interest statement.pdf
Copyright License Agreement 57210-Copyright license agreement.pdf
Peer-review Report 57210-Peer-review(s).pdf
Scientific Misconduct Check 57210-Scientific misconduct check.pdf
Scientific Editor Work List 57210-Scientific editor work list.pdf